Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Notice issued for attention of Members in respect of information regarding Postal Ballot and Updation of email address of the Members Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Analysts/Institutional Investor Meet/Con. Call Updates
Accumulate Rossari Biotech; target of Rs 843: KR Choksey
KR Choksey recommended accumulate rating on Rossari Biotech with a target price of Rs 843 in its research report dated October 27, 2023. Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Intimation of transcript of the Q2 and H1 FY24 Earnings Conference Call held on October 23, 2023
Buy Rossari Biotech; target of Rs 1015: YES Securities
YES Securities is bullish on Rossari Biotech has recommended buy rating on the stock with a target price of Rs 1015 in its research report dated October 24 2023. Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio Recording of Earnings Conference Call for Q2 FY24
Rossari Biotech Ltd. Results Earnings Call for Q2FY24
Conference Call with Rossari Biotech Ltd. Management and Analysts on Q2FY24 Performance and Outlook. Listen to the full earnings transcript. Q2FY24 Quarterly Result Announced for Rossari Biotech Ltd.
Specialty Chemical company Rossari Biotech announced Q2FY24 results: - Rossari Biotech Limited announces highest-ever quarterly performance with revenues of Rs 483.5 crore, up 14% YoY. - EBITDA stands at Rs. 63.6 crore, showing a growth of 13% YoY. - PAT increases by 38% YoY, reaching Rs. 32.9 crore. - EPS (Diluted) for the quarter stands at Rs. 6.0, compared to Rs. 4.3 in the previous year. Business Operations - Core divisions, HPPC and TSC, drive strong performance with revenue growth of 21% and 5% respectively. - AHN division experiences subdued performance due to seasonal softness in demand. - Expanded facility at Dahej to focus on HPPC products and producing ingredients for subsidiary companies. - Ethoxylation capacity at Dahej facility of Unitop Chemicals Private Limited to be expanded by 30,000 MTPA to meet growing demand in various industries. Result PDF
Rossari Biotech down almost 3% on profit booking
The company reported a 37 percent YoY increase in net profit at RS 33 crore and a revenue of Rs 483.5 crore, a 13.7 percent growth in the July-to-September quarter Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of extracts of Consolidated Un-audited Financial Results for quarter and half year ended September 30, 2023.